triazoles has been researched along with androstenedione in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 40 (47.06) | 18.2507 |
| 2000's | 32 (37.65) | 29.6817 |
| 2010's | 12 (14.12) | 24.3611 |
| 2020's | 1 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Borja, J; Pérez, N | 1 |
| Bowden, CR; Morris, DM; Tuman, RW; Wallace, NH | 1 |
| De Coster, R; Janssen, PA; Krekels, MD; Leonaers, A; Van Ginckel, R; Wouters, W | 1 |
| Bellens, D; Coene, MC; Janssen, PA; Lauwers, W; Le Jeune, L; Moereels, H; Roels, I; Vanden Bossche, H; Willemsens, G | 1 |
| Davenport, JD; Hirsch, KS; Holden, HE; Jones, CD; Krumkalns, EV; Stamm, N; Suhr, RG; Taylor, HM; Winter, MA | 1 |
| De Coster, R; Krekels, MD; Wouters, W | 1 |
| Brodie, A; Savinov, A; Wang, J; Yue, W | 1 |
| Koymans, LM; Moereels, H; Vanden Bossche, H | 1 |
| Balthazart, J; Foidart, A; Harada, N | 1 |
| Junker Walker, U; Nogués, V | 1 |
| Casebolt, TL; Eto, I; Grubbs, CJ; Kelloff, GJ; Lubet, RA; Steele, VE | 1 |
| Ahern, J; Dowsett, M; Iveson, TJ; Smith, IE; Smithers, DA; Trunet, PF | 1 |
| Blankenstein, MA; de Frankrijker, E; Donker, TH; Nortier, HW; Thijssen, JH; van der Wall, E | 1 |
| Detre, S; Dowsett, M; Grimshaw, R; Lee, K; Macaulay, VM; Rowlands, M | 1 |
| Callens, M; De Coster, R; Goeminne, N; Janssens, B; Van Ginckel, R; Wouters, L | 1 |
| Choate, JV; Resko, JA | 1 |
| Boyle, T; Dukes, M; Edwards, PN; Large, M; Smith, IK | 1 |
| Detre, S; Dowsett, M; Grimshaw, R; Rowlands, M | 1 |
| Cala, KM; Landrum, DP; Mahendroo, MS; Russell, DW | 1 |
| Dowsett, M | 2 |
| Durgam, VR; Tekmal, RR | 1 |
| Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
| Aparicio, LA; Carrion, RP; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Robertson, JF; Vorobiof, DA | 1 |
| Harada, N; Hatano, O | 1 |
| Flanagan, AM; Lea, CK | 1 |
| Dickson, RB; El-Ashry, D; Hannum, RS; Kern, FG; Kharbanda, S; Lopez, CA; Lorant, LA; McLeskey, SW; Tobias, CA; Trock, BJ; Zhang, L | 1 |
| Dowsett, M; Jacobs, S; Johnston, SR; Jones, A; Smith, IE; Trunet, P | 1 |
| Brodie, AM; Grigoryev, DN; Long, BJ; Thiantanawat, A; Tilghman, SL; Yue, W | 1 |
| Flanagan, AM; Lea, CK; Sarma, U | 1 |
| Bershteĭn, LM; Larionov, AA; Poroshina, TE; Zimarina, TS | 1 |
| Ahmadi, M; Delgado, PO; Nicholls, PJ; Perez, SF; Simons, C; Smith, HJ; Vinh, TK; Walters, HM | 1 |
| Blijham, GH; de Jong, PC | 1 |
| Coombes, RC; Harper-Wynne, C | 1 |
| Coombes, RC; Doody, D; Dowsett, M; English, J; Howes, A; Miall, S | 1 |
| Colciago, A; Motta, M; Negri-Cesi, P; Poletti, A | 1 |
| Bonneterre, J; Feutrie, ML | 1 |
| Calvo, L; Clack, G; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Perez-Carrion, R; Robertson, JF; Vorobiof, DA | 1 |
| Brodie, AM; Njar, VC | 1 |
| Coombes, RC; Dowsett, M; Harper-Wynne, C | 1 |
| Harvey, HA; Santen, RJ | 1 |
| Bajetta, E; Bichisao, E; Pozzi, P; Toffolatti, L; Zilembo, N | 1 |
| Criscuoli, M; Lippi, A; Maggi, CA; Mauro, S; Muratori, M; Palma, C | 1 |
| Auvray, P; Bichat, F; Genne, P | 1 |
| de Crémoux, P | 1 |
| Kerbrat, P; Lefeuvre, C | 1 |
| Albrecht, ED; Babischkin, JS; Burleigh, DW; Mayhew, TM; Pepe, GJ | 1 |
| Buzdar, A; Howell, A | 1 |
| Carlini, P; Casali, A; Cognetti, F; De Marco, S; Fabi, A; Frassoldati, A; Nardi, M; Paoloni, F; Papaldo, P; Ruggeri, EM | 1 |
| Albrecht, ED; Billiar, RB; Pepe, GJ; Zachos, NC | 1 |
| Dixon, JM; Miller, WR; Sahmoud, T; Stuart, M | 1 |
| Bergström, M; Bergström-Pettermann, E; Bonasera, TA; Carlström, K; Holte, J; Kirilovas, D; Långström, B; Naessen, T; Simberg, N | 1 |
| Bryant, M; Bulun, SE; Hsu, WT; Neely, K; Schultz, RA; Sebastian, S; Shozu, M; Takayama, K | 1 |
| Bigioni, M; Cirillo, R; Criscuoli, M; Iafrate, EM; Lippi, A; Lopez, G; Maggi, CA; Maggi, M; Mancina, R; Muratori, M | 1 |
| Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I | 1 |
| Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R | 1 |
| Bergström, M; Bergström-Petterman, E; Carlström, K; Kirilovas, D; Långström, B; Naessen, T | 1 |
| Hori, H; Kagawa, N; Waterman, MR; Yoshioka, S | 1 |
| Lykkesfeldt, AE; Sonne-Hansen, K | 1 |
| Delozier, T; Khayat, D; Spano, JP | 1 |
| Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E | 1 |
| Dubinett, SM; Fishbein, MC; Garban, HJ; Goodglick, L; Marquez-Garban, DC; Pietras, RJ; Weinberg, OK | 1 |
| Cernich, J; Jacobson, JD; Moore, WV; Popovic, J | 1 |
| Arteaga, CL; Miller, T; Shin, I | 1 |
| Brodie, A; Guo, Z; Macedo, LF; Qiu, Y; Sabnis, GJ; Tilghman, SL | 1 |
| Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP | 1 |
| Cheung, AM; Goss, PE; Hu, H; Qi, S | 1 |
| Andò, S; Barone, I; Casaburi, I; Catalano, S; Giordano, C; Gu, G; Lanzino, M; Marsico, S; Middea, E; Pellegrino, M; Rizza, P | 1 |
| Brodie, A; Goloubeva, O; Jelovac, D; Sabnis, G; Schayowitz, A | 1 |
| Blanchett, D; Demers, L; Goss, PE; Langecker, P; Ohorodnik, S; Santen, RJ; Settlage, J; Wang, S | 1 |
| Blanchett, D; Bondarenko, IN; Goss, P; Langecker, P; Manikhas, GN; Miller, WH; Pendergrass, KB | 1 |
| Dutta, U; Pant, K | 1 |
| Chen, S; Hong, Y; Rashid, R | 1 |
| Gallicchio, L; Helzlsouer, KJ; Macdonald, R; Rushovich, E; Wood, B | 1 |
| Chan, CC; Ho, PC; Lee, VC; Ng, EH; Yeung, WS | 1 |
| Gasco, M; Gonzales, GF; Gonzales-Castañeda, C; Tapia, V | 1 |
| Cheng, FX; Fu, J; Li, WH; Liu, GX; Shen, ZH; Tang, Y | 1 |
| Bane, F; Byrne, C; Conroy, RM; Gaora, PÓ; Hao, Y; Hill, AD; McBryan, J; McIlroy, M; O'Hara, J; Tibbitts, P; Vareslija, D; Young, LS | 1 |
| Gildea, JJ; Wang, J; Yue, W | 1 |
| Brodie, A; Golubeva, O; Kazi, A; Sabnis, GJ; Shah, P | 1 |
| Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW | 1 |
| Barman, P; Buzdar, AU; Desta, Z; Dudenkov, TT; Flockhart, DA; Goetz, MP; Ingle, JN; Kalari, KR; Northfelt, DW; Perez, EA; Robson, ME; Wang, L; Weinshilboum, RM; Williard, CV | 1 |
| Andò, S; Barone, I; Brown, PH; Fuqua, SA; Iacopetta, D; O'Malley, BW; Rechoum, Y; Rovito, D; Weigel, NL | 1 |
| Boberg, J; Christiansen, S; Draskau, MK; Frandsen, HL; Pedersen, M; Svingen, T; Taxvig, C | 1 |
| de Aguiar Marciano, LP; Lima Brigagão, MRP; Machado Viana, AL; Machado, SC; Martins, I; Rodrigues, MR; Souza Pereira, AF; Souza, BM | 1 |
20 review(s) available for triazoles and androstenedione
| Article | Year |
|---|---|
Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Letrozole; Nitriles; Triazoles | 1992 |
The control and biological importance of intratumoural aromatase in breast cancer.
Topics: Adenocarcinoma; Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Male; Mice; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Triazoles; Tumor Cells, Cultured | 1996 |
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles | 1999 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
Aromatase inhibitors and their application in breast cancer treatment*.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Mice; Nitriles; Tamoxifen; Triazoles | 2000 |
Drug and hormone interactions of aromatase inhibitors.
Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles | 1999 |
Aromatase inhibitors and their use in the sequential setting.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
Steroidal aromatase inhibitors in elderly patients.
Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles | 2000 |
[Aromatase inhibitors: pharmacological aspects].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Aromatase inhibitors: a review of clinical trials].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles | 2000 |
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
[Aromatase inhibitors in adjuvant setting in breast cancer].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles | 2004 |
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles | 2005 |
Use of aromatase inhibitors in children with short stature.
Topics: Adult; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Body Height; Child; Estrogens; Female; Growth Disorders; Humans; Letrozole; Male; Musculoskeletal System; Nitriles; Triazoles | 2004 |
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2006 |
Aromatase inhibitors: past, present and future in breast cancer therapy.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2008 |
[Progress in study of the structure, catalytic mechanism and inhibitors of aromatase].
Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Catalysis; Coumarins; Estrogens; Flavonoids; Humans; Inhibitory Concentration 50; Letrozole; Nitriles; Sesquiterpenes; Structure-Activity Relationship; Triazoles; Xanthones | 2012 |
15 trial(s) available for triazoles and androstenedione
| Article | Year |
|---|---|
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Aged; Aldosterone; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hydroxyprogesterones; Letrozole; Luteinizing Hormone; Male; Menopause; Middle Aged; Nitriles; Random Allocation; Testosterone; Thyrotropin; Time Factors; Triazoles | 1993 |
Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Carbon Radioisotopes; Double-Blind Method; Estrone; Female; Humans; Postmenopause; Triazoles; Tritium | 1993 |
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Female; Humans; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles | 1997 |
In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrone; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Nitriles; Postmenopause; Triazoles | 1995 |
Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy.
Topics: Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Female; Humans; Nitriles; Postmenopause; Prospective Studies; Receptors, Estrogen; Treatment Outcome; Triazoles | 1999 |
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Goserelin; Humans; Middle Aged; Ovary; Postmenopause; Premenopause; Triazoles | 1999 |
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Estrogens; Female; Humans; Injections, Intramuscular; Middle Aged; Nitriles; Triazoles | 1999 |
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radioimmunoassay; Receptors, Estrogen; Triazoles | 2002 |
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles | 2003 |
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?
Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles | 2003 |
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.
Topics: Androstenedione; Aromatase Inhibitors; Biological Assay; Breast Neoplasms; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Humans; Letrozole; Nitriles; Placebos; Postmenopause; Radioimmunoassay; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazoles | 2007 |
Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Steroid; Toremifene; Triazoles | 2007 |
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Pain; Nitriles; Testosterone; Triazoles | 2011 |
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial.
Topics: Adult; Androstenedione; Anti-Mullerian Hormone; Aromatase Inhibitors; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicular Fluid; Humans; Letrozole; Menotropins; Nitriles; Ovarian Follicle; Pregnancy; Pregnancy Rate; Triazoles | 2011 |
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Nitriles; Postmenopause; Testosterone; Triazoles | 2015 |
50 other study(ies) available for triazoles and androstenedione
| Article | Year |
|---|---|
Inhibition of peripheral aromatization in the male cynomolgus monkey by a novel nonsteroidal aromatase inhibitor (R 76713).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dose-Response Relationship, Drug; Estrone; Injections, Intravenous; Macaca fascicularis; Male; Pharmaceutical Vehicles; Triazoles | 1991 |
Aromatase in the human choriocarcinoma JEG-3: inhibition by R 76 713 in cultured cells and in tumors grown in nude mice.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Binding, Competitive; Choriocarcinoma; Female; Humans; Kinetics; Mice; Mice, Nude; Substrate Specificity; Testosterone; Triazoles; Tumor Cells, Cultured | 1991 |
R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis.
Topics: Adrenal Glands; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Cattle; Cytochrome P-450 Enzyme Inhibitors; Estrogens; Female; Male; Microsomes; Placenta; Rabbits; Rats; Spectrophotometry; Stereoisomerism; Swine; Testis; Triazoles | 1990 |
Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Benzhydryl Compounds; Chemical Phenomena; Chemistry; Female; Gonadotropins, Equine; Imidazoles; Microsomes; Molecular Structure; NADP; Ovary; Pyrazoles; Pyridines; Pyrimidines; Rats; Structure-Activity Relationship; Thiazoles; Triazoles; X-Ray Diffraction | 1990 |
Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Female; Kinetics; Ovary; Rats; Rats, Inbred Strains; Testosterone; Triazoles | 1990 |
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus | 1995 |
A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase).
Topics: Amino Acid Sequence; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Humans; In Vitro Techniques; Models, Molecular; Molecular Sequence Data; Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Alignment; Triazoles | 1995 |
Effects of steroidal and non steroidal aromatase inhibitors on sexual behavior and aromatase-immunoreactive cells and fibers in the quail brain.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Brain; Coturnix; Drug Implants; Immunoenzyme Techniques; Male; Nerve Fibers; Sexual Behavior, Animal; Testosterone; Triazoles | 1994 |
Changes induced by treatment with aromatase inhibitors in testicular Leydig cells of rats and dogs.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dogs; Genitalia, Male; Letrozole; Leydig Cells; Male; Nitriles; Rats; Species Specificity; Triazoles | 1994 |
Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
Topics: Adenocarcinoma; Aminoglutethimide; Androstenedione; Animals; Anticarcinogenic Agents; Aromatase Inhibitors; Drug Screening Assays, Antitumor; Estrus; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Triazoles | 1994 |
Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinogens; Disease Models, Animal; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Tamoxifen; Triazoles | 1996 |
Paradoxical effect of an aromatase inhibitor, CGS 20267, on aromatase activity in guinea pig brain.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Binding, Competitive; Brain; Enzyme Inhibitors; Estradiol; Estrone; Guinea Pigs; Kinetics; Letrozole; Male; Microsomes; Nitriles; Orchiectomy; Testosterone; Triazoles | 1996 |
The preclinical pharmacology of "Arimidex" (anastrozole; ZD1033)--a potent, selective aromatase inhibitor.
Topics: Adrenal Glands; Aminoglutethimide; Anastrozole; Androstenedione; Animals; Aromatase Inhibitors; Cortodoxone; Enzyme Inhibitors; Fadrozole; Female; Hormones; Humans; Macaca nemestrina; Male; Metyrapone; Nitriles; Organ Size; Potassium; Prostate; Rats; Rats, Wistar; Seminal Vesicles; Sodium; Triazoles; Uterus | 1996 |
Oestrogen formation in breast: clinical and biological importance.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Signal Transduction; Transfection; Triazoles; Tumor Cells, Cultured | 1996 |
Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androstenedione; Animals; Biological Assay; Decidua; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Estrogen Antagonists; Estrogens; Female; Fetal Death; Gene Expression Regulation, Enzymologic; In Situ Hybridization; Litter Size; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitriles; Placenta; RNA, Messenger; Steroids; Tamoxifen; Triazoles; Uterus | 1997 |
Aromatase inhibitors come of age.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Nitriles; Triazoles | 1997 |
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured | 1997 |
Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Carcinoma, Hepatocellular; Choriocarcinoma; Colforsin; Cycloheximide; Enzyme-Linked Immunosorbent Assay; Fadrozole; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Synthesis Inhibitors; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 1998 |
Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat.
Topics: Aging; Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Body Weight; Bone Resorption; Enzyme Inhibitors; Estradiol; Female; Nitriles; Ovariectomy; Rats; Rats, Sprague-Dawley; Testosterone; Tosyl Compounds; Triazoles | 1998 |
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Cell Line; Chloramphenicol O-Acetyltransferase; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factors; Fulvestrant; Humans; Letrozole; Luciferases; Mice; Mice, Nude; Nitriles; Ovariectomy; Polymerase Chain Reaction; Receptors, Progesterone; Recombinant Fusion Proteins; RNA, Messenger; Tamoxifen; Transcription, Genetic; Transfection; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured | 1998 |
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
Topics: Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell Division; Cells, Cultured; Choriocarcinoma; DNA Primers; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Fulvestrant; Humans; Letrozole; Microsomes; Nitriles; Placenta; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 1998 |
Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones.
Topics: Anastrozole; Androgen Antagonists; Androstenedione; Anilides; Animals; Bone Marrow; Enzyme Inhibitors; Estradiol; Estrogens; Female; Gene Expression Regulation; Macrophage Colony-Stimulating Factor; Molecular Weight; Nitriles; Ovariectomy; Polymerase Chain Reaction; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sex Characteristics; Tosyl Compounds; Transcription, Genetic; Triazoles | 1999 |
[Metabolism of the androgenic precursor androstenedione and effects of aromatase inhibitors in cultured blood lymphocytes].
Topics: Adolescent; Adult; Age Factors; Aged; Androstenedione; Aromatase Inhibitors; Bucladesine; Cells, Cultured; Dexamethasone; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Lymphocytes; Middle Aged; Nitriles; Triazoles | 1998 |
1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Benzofurans; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Ketones; Placenta; Pregnancy; Structure-Activity Relationship; Tetrazoles; Triazoles | 1999 |
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Southern; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Humans; Hydrogen-Ion Concentration; Isoenzymes; Male; Microsomes; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Triazoles; Tumor Cells, Cultured | 1999 |
Effect of the aromatase inhibitor, MEN 11066, on growth of two different MCF-7 sublines.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Benzofurans; Cell Division; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrone; Female; Humans; Microsomes; Placenta; Stereoisomerism; Testosterone; Triazoles; Tritium; Tumor Cells, Cultured | 2000 |
Developmental regulation of morphological differentiation of placental villous trophoblast in the baboon.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Bromodeoxyuridine; Cell Differentiation; Enzyme Inhibitors; Estradiol; Estrogens; Female; Ki-67 Antigen; Letrozole; Nitriles; Papio; Placenta; Pregnancy; Triazoles; Trophoblasts | 2001 |
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?
Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Retrospective Studies; Treatment Failure; Triazoles | 2001 |
Developmental regulation of baboon fetal ovarian maturation by estrogen.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Enzyme Inhibitors; Epithelium; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fetal Blood; Gestational Age; Letrozole; Mesoderm; Nitriles; Organ Size; Ovary; Papio; Pregnancy; Receptors, Estrogen; Testosterone; Triazoles | 2002 |
Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro.
Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Binding, Competitive; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Female; Granulosa Cells; Humans; Statistics, Nonparametric; Testosterone; Triazoles | 2003 |
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
Topics: Adipose Tissue; Adolescent; Adult; Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Child; Chromosome Mapping; Chromosomes, Human, Pair 15; Dexamethasone; Enzyme Inhibitors; Estradiol; Estrone; Fibroblasts; Glucocorticoids; Gynecomastia; Humans; Male; Molecular Sequence Data; Mutation; Nitriles; Promoter Regions, Genetic; RNA, Messenger; Transcription, Genetic; Triazoles | 2003 |
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Benzofurans; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gonadotropins, Equine; Humans; Liver; Mixed Function Oxygenases; Organ Size; Ovary; Placenta; Rats; Rats, Wistar; Steroids; Triazoles; Uterus | 2003 |
Characterization of [11C]vorozole binding in ovarian tissue in rats throughout estrous cycle in association with conversion of androgens to estrogens in vivo and in vitro.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Binding Sites; Enzyme Inhibitors; Estradiol; Estrous Cycle; Estrus; Female; In Vitro Techniques; Luteinizing Hormone; Ovary; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Triazoles | 2003 |
Characterization of stable human aromatase expressed in E. coli.
Topics: Amino Acid Sequence; Androstenedione; Arginine; Aromatase; Aromatase Inhibitors; Cell Membrane; Chaperonin 10; Chaperonin 60; Chloramphenicol; Cysteine; Electron Spin Resonance Spectroscopy; Enzyme Stability; Escherichia coli; Estradiol; Estrone; Fadrozole; Gene Expression; Humans; Letrozole; Molecular Sequence Data; Nitriles; Polymorphism, Genetic; Protein Structure, Secondary; Protein Synthesis Inhibitors; Recombinant Proteins; Solubility; Testosterone; Triazoles | 2004 |
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Culture Media; Dose-Response Relationship, Drug; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Letrozole; Nitriles; Receptors, Estrogen; Testosterone; Triazoles; Tumor Cells, Cultured | 2005 |
Aromatase inhibitors in human lung cancer therapy.
Topics: Anastrozole; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lung; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoblotting; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Nitriles; Ovariectomy; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Triazoles | 2005 |
ErbB receptor signaling and therapeutic resistance to aromatase inhibitors.
Topics: Acetyltransferases; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Corticosterone; Drug Resistance, Neoplasm; Female; Histone Acetyltransferases; Humans; Letrozole; Nitriles; Nuclear Receptor Coactivator 3; Oncogene Proteins; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Trans-Activators; Transcriptional Activation; Triazoles | 2006 |
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Topics: Androgen Receptor Antagonists; Androgens; Androstenedione; Aromatase; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dihydrotestosterone; Estradiol; Estrogen Receptor alpha; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; RNA, Small Interfering; Transfection; Triazoles | 2006 |
The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
Topics: Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Female; Humans; Letrozole; Lipids; Models, Chemical; Nitriles; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Toremifene; Triazoles; Uterus | 2007 |
Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol "in situ" production.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Bucladesine; Chromatin Immunoprecipitation; DNA; Electrophoretic Mobility Shift Assay; Estradiol; Estrogen Receptor alpha; Fas Ligand Protein; Follicle Stimulating Hormone; Genes, Reporter; HeLa Cells; Humans; Immune Tolerance; Letrozole; Luciferases; Male; Mice; Mice, Inbred BALB C; Mutation; Nitriles; Promoter Regions, Genetic; RNA, Messenger; Sertoli Cells; Sp1 Transcription Factor; Transcription, Genetic; Transfection; Triazoles; Up-Regulation | 2007 |
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
Topics: Androstadienes; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor Modulators; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Tamoxifen; Triazoles; Wortmannin | 2007 |
Binding features of steroidal and nonsteroidal inhibitors.
Topics: Amino Acids; Androgens; Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Catalytic Domain; Estrogens; Estrone; Female; Humans; Letrozole; Mutagenesis, Site-Directed; NADPH-Ferrihemoprotein Reductase; Neoplasms, Hormone-Dependent; Nitriles; Protein Conformation; Structure-Activity Relationship; Triazoles | 2011 |
Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis).
Topics: Adult; Altitude; Androstenedione; Aromatase; Aromatase Inhibitors; Cohort Studies; Dehydroepiandrosterone Sulfate; Estradiol; Hemoglobins; Humans; Letrozole; Male; Middle Aged; Nitriles; Oximetry; Peru; Polycythemia; Prospective Studies; Statistics, Nonparametric; Testosterone; Triazoles | 2012 |
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Letrozole; MAP Kinase Signaling System; Neoplasm Recurrence, Local; Nitriles; Nuclear Receptor Coactivator 3; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins; Up-Regulation | 2012 |
Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; CD24 Antigen; Cell Line; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Estradiol; Estrogen Receptor alpha; Female; Gene Expression; Humans; Hyaluronan Receptors; Letrozole; Neoplastic Stem Cells; Nitriles; RNA, Messenger; Spheroids, Cellular; Triazoles | 2013 |
Effect of selumetinib on the growth of anastrozole-resistant tumors.
Topics: Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; MAP Kinase Kinase 1; Mice; Mice, Nude; Nitriles; Ovariectomy; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays | 2013 |
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition Disorders; Estrone; Female; Flutamide; Maze Learning; Menopause; Nitriles; Ovariectomy; Rats, Inbred F344; Receptors, Androgen; Triazoles; Uterus | 2015 |
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.
Topics: Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; MCF-7 Cells; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Androgen; Tamoxifen; Triazoles | 2014 |
In vitro and in vivo endocrine disrupting effects of the azole fungicides triticonazole and flusilazole.
Topics: Androgen Antagonists; Androstenedione; Animals; Antifungal Agents; Azoles; Cyclopentanes; Endocrine Disruptors; Fungicides, Industrial; Male; Rats; Rats, Sprague-Dawley; Reproduction; Silanes; Triazoles | 2019 |
Endpoints as human biomarkers in exposure assessment of triazoles fungicides.
Topics: Adult; Androstenedione; Bile Acids and Salts; Biological Monitoring; Biomarkers; Endocrine Disruptors; Fungicides, Industrial; Glycine; Humans; Middle Aged; Occupational Exposure; Oxidative Stress; Rural Population; Testosterone; Triazoles; Urban Population | 2021 |